Diabetes technology: improving care, improving patient-reported outcomes and preventing complications in young people with Type 1 diabetes
Prahalad P, Tanenbaum M, Hood K, et al.
Diabetic Medicine. Pub online 22 January 2018
Leggi
Breaking news
High-Density Lipoprotein Function in Cardiovascular Disease and Diabetes Mellitus
He Y, Kothari V, Bornfeldt KE
Arterioscler Thromb Vasc Biol. Pub online 24 January 2018
Leggi
Reduced LongTerm Risk of Aortic Aneurysm and Aortic Dissection Among Individuals With Type 2 Diabetes Mellitus: A Nationwide ObservationalStudy
Avdic T, Franzén S, Zarrouk M, et al.
J Am Heart Assoc. Pub online 24 January 2018
Leggi
Flash forward: a review of flash glucose monitoring
Leelarathna L, Wilmot G
Diabetic Medicine. Pub online: 22 gennaio 2018.
Leggi
Continuous glucose monitoring in pregnant women with Type 1 diabetes: benefits for mothers, using pumps or pens, and their babies
Feig DS, Murphy HR
Diabetic Medicine. Pub. online 20 Jan 2018
Leggi
Diabetes and technology in 2030: a utopian or dystopian future?
Kerr D, Axelrod C, Hoppe C, et al.
Diabetic Medicine. Pub online 22 January 2018
Leggi
Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results from the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)
Mahaffey KW, Neal B, Perkovic V, et al.
Circulation 2018;137:323-34
Leggi
Cardiovascular Safety, Long-Term Noncardiovascular Safety, and Efficacy of Sodium–Glucose Cotransporter 2 Inhibitors in Patients with Type 2Diabetes Mellitus: A Systemic Review and Meta-Analysis With Trial Sequential Analysis
Zhang XL, Zhu QQ, Chen YH, et al.
J Am Heart Assoc. Pub. online January 20, 2018
Leggi
Association of Bariatric Surgery Using Laparoscopic Banding, Roux-en-Y Gastric Bypass, or Laparoscopic Sleeve Gastrectomy vs Usual Care Obesity Management with All-Cause Mortality
Reges O, Greenland P, Dicker D, et al.
JAMA 2018;319(3):279-90
Leggi
Canagliflozin: Cui Bono? (Editorial)
Cavender MA, Kosiborod M
Circulation 2018;137:335-7
Leggi